Skip to main content

Table 3 Review of the literature on neuroimaging data in cystinosis patients.

From: Neuropsychological and neuroanatomical phenotype in 17 patients with cystinosis

Study name

Neurological symptoms

Psychiatric symptoms

Neuroimaging data

Control groups

number

type

sequence type

abnormalities

Cochat, 1985

repeated seizures, tremor, mental retardation, pseudobulbar or pyramidal syndrome

 

10

TDM

-

brain atrophy

10 control patients with another primary renal disease (mean age=11,8 years, SD=3,7)

Jonas, 1987

impairment in visual perception, moderate bilateral sensorineural hearing loss, mild peripheral neuropathy,

depression, lack of motivation, inability to function independently. One year later: confusion with impaired short-term memory

1

TDM

-

cerebral atrophy

no

Nichols, 1990

NA

 

10

1.5T MRI

T1, T2, DP

subjective cerebral atrophy in 10 of the 11 patients (7: moderate to severe, 3: mild)

no

1

TDM

   

Broyer, 1996

neurological complications in 7 patients with 2 forms: - encephalopathie (cerebellar and pyramidal signs, mental deterioration and pseudo-bulbar palsy): 4/7 - stroke-like episode with coma and hemiplegia or milder symptoms

 

2

1.5T MRI

T2

moderate brain atrophy, spontaneously regressive T2 hyperintensities in the 2 lenticular nuclei and in the caudate nucleus, a right temporo-occipital area of demyelinization

no

6

TDM

-

brain atrophy (6/6); multiple areas of mineralization (4/6) including basal ganglia and frontal WM; frontotemporal ischemic stroke (1/6)

 

Dogulu, 2004

Documented ICHT (papilledema, CSF opening pressure greater than 200mm of H2O)

 

7

1.5T MRI

NA

mild diffuse atrophy in 1 patient

no

1

TDM

 

none

 

Muller, 2008

progressive distal myopathy; cerebellar syndrome regressive under cysteamin

recurrent depressive episodes

2

1,5T MRI

NA

cerebral atrophy (the second MRI performed 11 years later did not reveal any progression of the atrophy)

no

1

FDG PET

 

none

 

Ulmer, 2009

none

 

9

1.5T MRI

T1, T2, DTI, 1H MR spectroscopy

- 4 mildly or moderately enlarged ventricles,

- a mesial slerosis of the hippocampus,

- a developmental venous anomaly

no

Berger, 2009

increasing neck pain and left hand and finger numbness; impaired coordination in both upper extremities; dysmetria (L>R), spasticity in both legs, strength deficit (4/5), unable to walk without assistance, pyramidal syndrome, diminished position sense in left , fingers and in left lower extremity, diminished vibratory sense in both lower extremities, impaired in pinprick and temperature sensation on the right side, and focal seizures

 

1

1,5T MRI

T2, FLAIR

T2 and FLAIR hyperintensities extended throught the brainstem into both internal capsules; small subcortical lesions in both parietal lobes

no

1

Spinal chord MRI

 

edematous cord along the entire extent of the cervical cord with contrast-enhancing lesionsa

 

Trauner, 2010

NA

 

46

1,5T MRI

T1

- 25 N,

- 11 mild volume loss,

- 5 moderate to severe volume loss,

- 5 isolated Chiari I malformation;

- No difference in motor coordination between different MRI groups (but very small number of patients per group); No age-related MRI findings

49 controls [2-17] years

Bava, 2010

none

 

21b

1,5T MRI

3DT1, DTI 6 directions

8/24 cortical or central atrophy; significantly decreased FA in the following manually defined ROI: bilateral superior parietal lobule and right inferior parietal lobule, but not in temporal ROI, in cystinosis versus controls; in children older than 5: positive relationship between FA in the RIPL and performance on the Beery VMI test (visuospatial performance); positive correlation between age and FA in the RIPL, LIPL and LSPL in cystinosis patients but not in controls

24 TD age-matched controls

Rogers, 2010

3/6 had intracranial hypertension (age range [19-22]), all were post-renal transplant, 1 marked optic nerve atrophy, 1 papilledema, 2 wide optic nerve sheath diameter measured with a B-scan ultrasound; 3/3 optic nerve sheath fenestration, 1/3 VPD

 

3

1,5T MRI

NA

N

no

Marquardt, 2013

Posterior Reversible Encephalopathy Syndrome (PRES): generalized seizures, headache, hypertension, vigilance deterioration

 

1

1,5T MRI

FLAIR, ADC, contrast enhanced MR angiogram

parieto-occipital and fronto-parietal mild oedematous swelling

no

Cazals, 2013

encephalopathy: stroke, then gradually walkind difficulties, cerebellar and frontal pyramidal syndrome

 

1

1,5T (and 3T 3 years later)

Diffusion, FLAIR, T2*

diffuse atrophy, multiple ischemic lesions in the semi-oval centre, T2 hyperintensity in the periventricular areas, a few frontal sub-cortical T2* hypointensity and slight uptake of contrast in the pervascular spaces in the fronto-parietal WM and central grey nuclei

no

 

CT angiography

 

N

 

Neutel, 2013

sudden onset of speech and gait disturbance

 

1

1,5T MRI

DWI, angioMRI

recurrent strokes caused by intracranial arterial stenosis (right internal carotid artery stenosis and right middle cerebral artery stenosis)

no

Ballantyne, 2013

NA

 

16

1,5T MRI

NA

12: N; 1: Chiari I malformation; 3: moderate cortical volume loss for age

MRI results from an earlier study

Aly, 2014

NA

 

13

1,5T MRI

NA

7/13 cortical brain atrophy, dysmyelination

13 age- and sex-matched healthy controls

Rao, 2015

10/53 had Chiari I malformation, 2 of the 10 were symptomatic

 

53

1,5T MRI

3DT1

10/53 (18,9%) Chiari I malformation (>5mm) or tonsillar ectopia (3-5mm), 1 syrinx, 1 syringohydromyelia

120 healthy controls: 2 (1,6%) Chiari I or tonsillar ectopia

Martin-Begué, 2016

Intracranial Hypertension in 4/8 with papilledema and confirmed high CSF pressure (at the age of 6-10 years); 1/4 symptomatic (had a Arnold-Chiari anomaly and enlarged ventricules); 2/4 VPD

 

4

1,5T MRI

NA

1 Arnold-Chiari and enlarged ventricules; 1 great distension of the perioptic subarachnoid space; 2N

 
  1. aa spinal cord biopsy was performed: chronic active demyelinating myelitis with lymphocytic vasculitis, atypical astrocytes, and microglial clusters ; CSF: lymphocytic pleocytosis, elevated protein and increased IgG synthesis
  2. b2 exclusions for motion artifacts, 1 for susceptibility artifact